Developing a complex intervention to improve prescribing safety in primary care: Mixed methods feasibility and optimisation pilot study

BMJ Open

Volumn 4, Issue 1, 2014, Pages

  Grant, Aileen M ^a   Guthrie, Bruce ^a   Dreischulte, Tobias ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING BETA 2 AGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; SHORT ACTING BETA AGONIST; THEOPHYLLINE; UNCLASSIFIED DRUG; WARFARIN;

ARTICLE; ASTHMA; CONTROLLED STUDY; DATA DRIVEN QUALITY IMPROVEMENT IN PRIMARY CARE; DISEASE CONTROL; DRUG EFFICACY; DRUG SAFETY; FEASIBILITY STUDY; GENERAL PRACTICE; GENERAL PRACTITIONER; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL STAFF; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHYSICIAN; PILOT STUDY; PRESCRIPTION; PRIMARY MEDICAL CARE; SCIENTIST; SEMI STRUCTURED INTERVIEW; SOCIOECONOMICS; TOTAL QUALITY MANAGEMENT; PATIENT SAFETY; PRIMARY HEALTH CARE; STANDARDS;

DRUG PRESCRIPTIONS; FEASIBILITY STUDIES; HUMANS; PATIENT SAFETY; PILOT PROJECTS; PRIMARY HEALTH CARE; QUALITY IMPROVEMENT;

EID: 84892873297     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004153     Document Type: Article

References (42)

1. Gandhi TK, Weingarten SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003;348:1556-64. (Pubitemid 36437933)
2. Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse events among older persons in the ambulatory setting. J Am Med Assoc 2003;289:1107-16. (Pubitemid 37430324)
3. Pirmohamed MJ, Meakin S, Green C, et al. Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18 820 patients. Br Med J 2004;329:15-19. (Pubitemid 38869995)
4. Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007;63:136-47. (Pubitemid 46072098)
5. Dreischulte T, Grant A, McCowan C, et al. Quality and safety of medication use in primary care: consensus validation of a new set of explicit medication assessment criteria and prioritisation of topics for improvement. BMC Clin Pharmacol 2012;12:5.
6. Guthrie B, McCowan C, Davey P, et al. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ 2011;342:d3514.
7. Howard RL, Avery AJ, Howard PD, et al. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003;12:280-5. (Pubitemid 36981325)
8. Thomsen LA, Winterstein AG, Sondergaard B, et al. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007;41:1411-26. (Pubitemid 47311361)
9. Department of Health. An organisation with a memory: report of an expert group on learning from adverse events in the NHS. 2000.
10. Smith J. Building a safer NHS for patients: improving medication safety. London: Department of Health, 2004.
11. Avery AJ, Rodgers S, Cantrill JA, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet 2012;379:1310-19.
12. Dreischulte T, Grant A, Donnan P, et al. A cluster randomised stepped wedge trial to evaluate the effectiveness of a multifaceted information technology-based intervention in reducing high-risk prescribing of non-steroidal anti-inflammatory drugs and antiplatelets in primary care: the DQIP study protocol. Implement Sci 2012;7:24.
13. Medical Research Council. A framework for the development and evaluation of RCTs for complex interventions to improve health. London: Medical Research Council, 2000.
14. Campbell M, Fitzpatrick R, Haines A, et al. Framework for design and evaluation of complex interventions to improve health. BMJ 2000;321:694-6.
15. O'Brien MA, Rogers S, Jamtvedt G, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2009;4:CD000409.
16. Farmer AP, Legare F, Turcot L, et al. Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database Syst Revi 2008;(3):CD004398.
17. Jamtvedt G, Young JM, Kristoffersen DT, et al. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2009;(4).
18. Gage BF, Waterman AD, Shannon W, et al. Validation of a clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. J Am Med Assoc 2001;285:2864-70. (Pubitemid 32537350)
19. Ritchie J, Spencer L, O'Connor W. Carrying out qualitative analysis. In: Ritchie J, Lewis J. eds Qualitative research practice, a guide for social science students and researchers. London: Sage, 2003.
20. Camm AJ KP, Lip GYH, Schotten U, et al. Guidelines for the management of atrial fibrillation. Eurospace 2010;12:1360-420.
21. Department of Health. Investing in General Practice-the New General Medical Services Contract. 2003.
22. British Medical Association. Focus on QOF payments. http://bma.org.uk/ practical-support-at-work/contracts/independent-contractors/qof-guidance/ focus-qof-payments (accessed 25 Nov 2013).
23. Campbell S, Chauhan U, Lester H. Primary Medical Care Provider Accreditation (PMCPA): pilot evaluation. Br J Gen Pract 2010; e295-301.
24. Bradley F, Wiles R, Kinmonth A-L, et al. Development and evaluation of complex interventions in health services research: case study of the Southampton heart integrated care project (SHIP). BMJ 1999;318:711-15. (Pubitemid 29191997)
25. Van Hecke A, Verhaeghe S, Grypdonck M, et al. Systematic development and validation of a nursing intervention: the case of lifestyle adherence promotion in patients with leg ulcers. J Adv Nurs 2011;67:662-76.
26. Corrrigan M, Cupples ME, Smith SM, et al. The contribution of qualitative research in designing a complex intervention for secondary prevention of coronary heart disease in two different healthcare systems. BMC Health Serv Res 2006;6:90.
27. Cresswell K, Sadler S, Rodgers S, et al. An embedded longitudinal multi-faceted qualitative evaluation of a complex cluster randomized controlled trial aiming to reduce clinically important errors in medicines management in general practice. Trials 2012;13:78.
28. Grant A, Dreischulte T, Treweek S, et al. Study protocol of a mixed-methods evaluation of a cluster randomised trial to improve the safety of NSAID and antiplatelet prescribing: data-driven quality improvement in primary care. Trials 2012;13:154.
29. Grant A, Treweek S, Dreischulte T, et al. Process evaluations for cluster-randomised trials of complex interventions: a proposed framework for design and reporting. Trials 2013;14:15.
30. Gallagher P, Ryan C, Byrne S, et al. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008;46:72-83. (Pubitemid 351233792)
31. Naugler CT, Brymer C, Stolee P, et al. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 2000;7:103-7.
32. Fick DM, Copper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropraite medication use in older adults, resulting of a US consenus panel of experts. Arch Intern Med 2003;163:2716-24. (Pubitemid 37517412)
33. Avery A, Dex G, Mulvaney C, et al. Development of prescribing-safety indicators for GPs using the RAND appropriateness method. Br J Gen Pract 2011;61:e526-36.
34. Pont LG, Denig P, van der Molen T. Validity of performance indicators for assessing prescribing quality: the case of asthma. Eur J Clin Pharmacol 2004;59:833-40. (Pubitemid 38221662)
35. Dreischulte T, Johnson J, McAnaw J, et al. Medication assessment tool to detect care issues from routine data: a pilot study in primary care. Int J Clin Pharm 2013;35:1063-74.
36. Hemming K, Chilton PJ, Lilford RJ, et al. Bayesian cohort and cross-sectional analyses of the PINCER trial: a pharmacist-led intervention to reduce medication errors in primary care. PLoS ONE 2012;7:e38306.
37. Nieuwlaat R, Capucci A, Lip GY, et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2006;27:3018-26. (Pubitemid 44963431)
38. Holt TA, Hunter TD, Gunnarsson C, et al. Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey. Br J Gen Pract 2012; 62: e710-17.
39. Ogilvie IM, Newton N, Welner S. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 2010;123:638-45.
40. Pugh D, Pugh J, Mead GE. Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing 2011;40:675-83.
41. Campbell SM, Cantrill JA, Roberts D. Prescribing indicators for UK general practice: Delphi consultation study. BMJ 2000;321:425-8. (Pubitemid 30609449)
42. Campbell S, Hann M, Hacker J, et al. Quality assessment for three common conditions in primary care: validity and reliability of review criteria developed by expert panels for angina, asthma and type 2 diabetes. Qual Saf Health Care 2002;11:125-30. (Pubitemid 35265274)